In a landscape where science and technology are two of the most rapidly growing fields, pharmaceutical companies face the dual challenge of remaining innovative and maintaining operational efficiency. Technology transfers emerge as a critical step in allowing drug developers to focus on their core competencies, while leveraging the specialized infrastructure and expertise of contract development and manufacturing organizations (CDMOs) to advance efficient manufacturing processes. This synergy not only allows for an accelerated time to market but also ensures all stages of a drug development program are handled by experts, fostering innovation and avoiding costly setbacks.
This whitepaper outlines essential strategies and industry insights for executing successful technology transfers in the pharmaceutical sector. We explore four key focus areas: knowledge transfer, equipment and utilities, control strategy, and manufacturing strategy. By meticulously addressing these elements, drug developers can ensure timely market entry, maintain product quality, and meet regulatory standards throughout the drug lifecycle.